(Q38070780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278681%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

review article

1 reference

title

Viable screening targets related to the bacterial cell wall (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278681%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278681%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Lynn L Silver

series ordinal

1

1 reference

28 August 2017

language of work or name

English

0 references

publication date

26 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278681%20AND%20SRC:MED&resulttype=core&format=json

Annals of the New York Academy of Sciences

21 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278681%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

1277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278681%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

29-53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278681%20AND%20SRC:MED&resulttype=core&format=json

The discovery of cell wall active antibacterial antibiotics

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Does the cell wall of bacteria remain a viable source of targets for novel antibiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Robust Salmonella metabolism limits possibilities for new antimicrobials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Drugs for bad bugs: confronting the challenges of antibacterial discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Riboswitches: discovery of drugs that target bacterial gene-regulatory RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Challenges of antibacterial discovery revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Discovery research: the scientific challenge of finding new antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Challenges of antibacterial discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Multi-targeting by monotherapeutic antibacterials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

How many modes of action should an antibiotic have?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Prospective screening of novel antibacterial inhibitors of dihydrofolate reductase for mutational resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Cytoplasmic steps of peptidoglycan biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Bacterial cell wall assembly: still an attractive antibacterial target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Peptidoglycan biosynthesis machinery: a rich source of drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Exploitation of structural and regulatory diversity in glutamate racemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

tagO is involved in the synthesis of all anionic cell-wall polymers in Bacillus subtilis 168.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Mureidomycin A, a new inhibitor of bacterial peptidoglycan synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

New noncovalent inhibitors of penicillin-binding proteins from penicillin-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Lipid II as a target for antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Glycopeptides: Update on an old successful antibiotic class

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

DEG: a database of essential genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

The mechanism of action of fosfomycin (phosphonomycin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Biological costs and mechanisms of fosfomycin resistance in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Development of a whole-cell assay for peptidoglycan biosynthesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Identification and characterization of new inhibitors of the Escherichia coli MurA enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

A novel inhibitor that suspends the induced fit mechanism of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

2-Aminotetralones: novel inhibitors of MurA and MurZ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

UDP-N-acetylglucosamine enolpyruvyl transferase as a potential target for antibacterial chemotherapy: recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

UDP-N-acetylmuramic acid (UDP-MurNAc) is a potent inhibitor of MurA (enolpyruvyl-UDP-GlcNAc synthase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Discovery of the first antibacterial small molecule inhibitors of MurB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

4-Alkyl and 4,4'-dialkyl 1,2-bis(4-chlorophenyl)pyrazolidine-3,5-dione derivatives as new inhibitors of bacterial cell wall biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Two diarylurea electron transport inhibitors reduce Staphylococcus aureus hemolytic activity and protect cultured endothelial cells from lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Structure and function of the Mur enzymes: development of novel inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Structure, function and dynamics in the mur family of bacterial cell wall ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Design and synthesis of novel N-benzylidenesulfonohydrazide inhibitors of MurC and MurD as potential antibacterial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Benzylidene rhodanines as novel inhibitors of UDP-N-acetylmuramate/L-alanine ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: design, synthesis, crystal structures, and biological evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Pulvinones as bacterial cell wall biosynthesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

2-Phenyl-5,6-dihydro-2H-thieno[3,2-c]pyrazol-3-ol derivatives as new inhibitors of bacterial cell wall biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Identification of an inhibitor of the MurC enzyme, which catalyzes an essential step in the peptidoglycan precursor synthesis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Structure-based optimization of MurF inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

MurF inhibitors with antibacterial activity: effect on muropeptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Are natural products still the best source for antibacterial discovery? The bacterial entry factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Self-protection mechanism in D-cycloserine-producing Streptomyces lavendulae. Gene cloning, characterization, and kinetics of its alanine racemase and D-alanyl-D-alanine ligase, which are target enzymes of D-cycloserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

The alanine racemase of Mycobacterium smegmatis is essential for growth in the absence of D-alanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Genes required for mycobacterial growth defined by high density mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Structure of the Mycobacterium tuberculosis D-Alanine:D-Alanine Ligase, a Target of the Antituberculosis Drug D-Cycloserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Phosphonopeptides as Antibacterial Agents: Mechanism of Action of Alaphosphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Staphylococcus haemolyticus contains two D-glutamic acid biosynthetic activities, a glutamate racemase and a D-amino acid transaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Glutamate racemase as a target for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

4-Substituted D-glutamic acid analogues: the first potent inhibitors of glutamate racemase (MurI) enzyme with antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): pyridodiazepine amines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase (MurI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Modeling bacterial UDP-HexNAc: polyprenol-P HexNAc-1-P transferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

A family of UDP-GlcNAc/MurNAc: polyisoprenol-P GlcNAc/MurNAc-1-P transferases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Biosynthesis of N-acetylglucosamine-P-P-dolichol, the committed step of asparagine-linked oligosaccharide assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Selective inhibition of the bacterial translocase reaction in peptidoglycan synthesis by mureidomycins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

MraY Inhibitors as Novel Antibacterial Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Identification of active-site inhibitors of MurG using a generalizable, high-throughput glycosyltransferase screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Identification of selective inhibitors for the glycosyltransferase MurG via high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

A neutral diphosphate mimic crosslinks the active site of human O-GlcNAc transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Assembly of the endoplasmic reticulum phospholipid bilayer: the phosphatidylcholine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Identification of FtsW as a transporter of lipid-linked cell wall precursors across the membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Bioinformatics identification of MurJ (MviN) as the peptidoglycan lipid II flippase in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Bacillus subtilis homologs of MviN (MurJ), the putative Escherichia coli lipid II flippase, are not essential for growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Resistance mapping and mode of action of a novel class of antibacterial anthranilic acids: evidence for disruption of cell wall biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Chemical genetic identification of peptidoglycan inhibitors potentiating carbapenem activity against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Resistance to antibiotics mediated by target alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

beta-lactams: variations on a chemical theme, with some surprising biological results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Interactions between penicillin-binding proteins (PBPs) and two novel classes of PBP inhibitors, arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Structure-guided design of cell wall biosynthesis inhibitors that overcome β-lactam resistance in Staphylococcus aureus (MRSA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Potential transition state analogue inhibitors for the penicillin-binding proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Soluble penicillin-binding protein 2a: beta-lactam binding and inhibition by non-beta-lactams using a 96-well format.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

4-quinolones as noncovalent inhibitors of high molecular mass penicillin-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Monofunctional transglycosylases are not essential for Staphylococcus aureus cell wall synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Moenomycin family antibiotics: chemical synthesis, biosynthesis, and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

The monofunctional glycosyltransferase of Escherichia coli localizes to the cell division site and interacts with penicillin-binding protein 3, FtsW, and FtsN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Antibacterial activity of synthetic analogues based on the disaccharide structure of moenomycin, an inhibitor of bacterial transglycosylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Targeting the forgotten transglycosylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Domain requirement of moenomycin binding to bifunctional transglycosylases and development of high-throughput discovery of antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Screening strategies for discovery of antibacterial natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

A streamlined metabolic pathway for the biosynthesis of moenomycin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Crystal structure of the membrane-bound bifunctional transglycosylase PBP1b from Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Crystal structure of Staphylococcus aureus transglycosylase in complex with a lipid II analog and elucidation of peptidoglycan synthesis mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Modular synthesis of diphospholipid oligosaccharide fragments of the bacterial cell wall and their use to study the mechanism of moenomycin and other antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

The Methylerythritol Phosphate Pathway and its Significance as a Novel Drug Target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Fosmidomycin, a novel chemotherapeutic agent for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Fosmidomycin Resistance in Adenylate Cyclase Deficient (cya) Mutants ofEscherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr): a review of the synthesis and biological evaluation of recent inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

HIV-1 Integrase Inhibitor-Inspired Antibacterials Targeting Isoprenoid Biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Identification of multiple genes encoding membrane proteins with undecaprenyl pyrophosphate phosphatase (UppP) activity in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

THE CONCENTRATION OF GLUCOSAMINE IN NORMAL AND PATHOLOGICAL SERA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Characterization of the essential gene glmM encoding phosphoglucosamine mutase in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Structure of a small-molecule inhibitor complexed with GlmU from Haemophilus influenzae reveals an allosteric binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

High-throughput screening identifies novel inhibitors of the acetyltransferase activity of Escherichia coli GlmU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

In Vitro Validation of Acetyltransferase Activity of GlmU as an Antibacterial Target in Haemophilus influenzae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Antibiotic discovery in the twenty-first century: current trends and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Bioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Chemistry and biology of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

The mechanism of action of ramoplanin and enduracidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Bacitracin: an inhibitor of the dephosphorylation of lipid pyrophosphate, an intermediate in the biosynthesis of the peptidoglycan of bacterial cell walls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Amphomycin inhibits phospho-N-acetylmuramyl-pentapeptide translocase in peptidoglycan synthesis of Bacillus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Amplification of the bacA gene confers bacitracin resistance to Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

The effect of bacitracin on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

The role of Staphylococcus aureus sortase A and sortase B in murine arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Sortase as a target of anti-infective therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Sortase transpeptidases: insights into mechanism, substrate specificity, and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Activation of Inhibitors by Sortase Triggers Irreversible Modification of the Active Site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Discovery and structure-activity relationship analysis of Staphylococcus aureus sortase A inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Probing teichoic acid genetics with bioactive molecules reveals new interactions among diverse processes in bacterial cell wall biogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Wall teichoic acid function, biosynthesis, and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Discovery of a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Discovering new antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Tearing down the wall: peptidoglycan metabolism and the WalK/WalR (YycG/YycF) essential two-component system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Genetic analysis and functional characterization of the Streptococcus pneumoniae vic operon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Essentiality, bypass, and targeting of the YycFG (VicRK) two-component regulatory system in gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

The essential two-component regulatory system encoded by yycF and yycG modulates expression of the ftsAZ operon in Bacillus subtilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Constitutive expression of PcsB suppresses the requirement for the essential VicR (YycF) response regulator in Streptococcus pneumoniae R6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Peptidoglycan crosslinking relaxation plays an important role in Staphylococcus aureus WalKR-dependent cell viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Walkmycin B targets WalK (YycG), a histidine kinase essential for bacterial cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Isolation and characterization of signermycin B, an antibiotic that targets the dimerization domain of histidine kinase WalK

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Novel antibacterial compounds specifically targeting the essential WalR response regulator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Bridging cell wall biosynthesis and bacterial morphogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Invariant Amino Acids in the Mur Peptide Synthetases of Bacterial Peptidoglycan Synthesis and Their Modification by Site-Directed Mutagenesis in the UDP-MurNAc:l-Alanine Ligase from Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Binding of a non- β -lactam antibiotic to penicillin-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12006

Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.39.1047

Identifiers

DOI

10.1111/NYAS.12006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278681%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23278681%20AND%20SRC:MED&resulttype=core&format=json